Patents by Inventor Lilach AVIGDOR

Lilach AVIGDOR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220203088
    Abstract: Disclosed are compositions for methods of transporting of a vector, therapeutic, detectable, or combination thereof across a cell membrane of a cell. Also disclosed are methods of detecting and/or treating a tumor or cancer cell using a vector, therapeutic, detectable, or combination thereof either alone or in combination with applying alternating electric fields.
    Type: Application
    Filed: December 22, 2021
    Publication date: June 30, 2022
    Inventors: Tali Voloshin-Sela, Lilach Avigdor, Yaara Porat, Helena Mumblat
  • Publication number: 20220096818
    Abstract: Disclosed herein are methods for increasing sensitivity of a cancer cell to alternating electric fields by administering an AKT inhibitor, a mammalian target of rapamycin (mTOR) inhibitor, a Phosphatidylinositol 3-Kinase (PI3K) inhibitor, and/or a Glycogen synthase kinase 3? (GSK3?) inhibitor. Disclosed are methods of increasing treatment efficacy comprising applying alternating electric fields to a target site of the subject for a period of time, the alternating electric fields having a frequency and field strength, wherein the target site comprises one or more cancer cells, and administering a therapeutically effective amount of one or more of an mTOR inhibitor, AKT inhibitor, PI3K inhibitor, or GSK3? inhibitor to the subject.
    Type: Application
    Filed: August 3, 2021
    Publication date: March 31, 2022
    Inventors: Tali Voloshin-Sela, Lilach Avigdor, Anat Klein-Goldberg
  • Publication number: 20220088403
    Abstract: Disclosed are methods of inhibiting a coronavirus from infecting or replicating in a cell comprising exposing the cell to an alternating electric field for a period of time, the alternating electric field having a frequency and field strength, wherein the frequency and field strength of the alternating electric field inhibits coronavirus infection or replication. Disclosed are methods of reducing coronavirus copy number per cell comprising exposing the cell to an alternating electric field for a period of time, the alternating electric field having a frequency and field strength, wherein the frequency and field strength of the alternating electric field reduces coronavirus copy number in the cell. Disclosed are methods of treating a subject infected with coronavirus comprising applying an alternating electric field to a target site of the subject for a period of time, the alternating electric field having a frequency and field strength, wherein the target site comprises one or more coronavirus infected cells.
    Type: Application
    Filed: September 17, 2021
    Publication date: March 24, 2022
    Inventors: Tali Voloshin-Sela, Lilach Avigdor, Yaara Porat, Moshe Giladi, Helena Are Yaara, Helena Mumblat
  • Publication number: 20210395722
    Abstract: Disclosed are methods of increasing proliferation of CD8+ T cells comprising exposing a target site to an alternating electric field for a period of time, the alternating electric field having a frequency and field strength, wherein the frequency and field strength of the alternating electric field increases proliferation of CD8+ T cells at the target site. Disclosed are methods of generating a pro-inflammatory response in a target site comprising exposing the target site to an alternating electric field for a period of time, the alternating electric field having a frequency and field strength, wherein the frequency and field strength of the alternating electric field generates a pro-inflammatory response at the target site.
    Type: Application
    Filed: June 18, 2021
    Publication date: December 23, 2021
    Inventors: Tali Voloshin-Sela, Lilach Avigdor
  • Publication number: 20210379362
    Abstract: Autoinflammatory and mitochondrial disorders can be treated by positioning a plurality of electrodes in or on a subject's body, and applying an AC voltage between the plurality of electrodes so as to impose an alternating electric field through the tissue that is being affected by the autoinflammatory or mitochondrial disease. The frequency and field strength of the alternating electric field are selected such that the alternating electric field inhibits inflammation or mitochondrial disorders in the tissue.
    Type: Application
    Filed: June 25, 2021
    Publication date: December 9, 2021
    Applicant: Novocure GmbH
    Inventors: Stuart SMITH, Lilach AVIGDOR, Tali VOLOSHIN-SELA